Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,748
Total Claims
$780K
Drug Cost
309
Beneficiaries
$2,523
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-96%
Opioid rate vs peers
0.1% vs 2.6% avg
+136%
Cost per patient vs peers
$2,523 vs $1,068 avg
+51%
Brand preference vs peers
13.6% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
26
Opioid Claims
$968
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,761 claims · $549K
Generic: 23,933 claims · $229K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 872 | $150K |
| Lipase/Protease/Amylase | 53 | $28K |
| Mirabegron | 203 | $25K |
| Empagliflozin | 134 | $23K |
| Linagliptin | 138 | $20K |
| Rivaroxaban | 120 | $19K |
| Dulaglutide | 20 | $16K |
| Fluticasone/Umeclidin/Vilanter | 37 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 68 | $14K |
| Linaclotide | 25 | $14K |
| Atorvastatin Calcium | 1,443 | $11K |
| Fluticasone Propion/Salmeterol | 23 | $9,687 |
| Carbidopa/Levodopa | 44 | $9,622 |
| Sitagliptin Phosphate | 42 | $9,048 |
| Gabapentin | 1,236 | $8,513 |
Prescribing Profile
Patient Profile
78
Avg Age
67%
Female
2.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data